| Conference II | University of California, San Diego | Gene Therapy Initiative 1st Annual Symposium |
$27,500 |
| Clinical Trial Stage Projects | University of California, San Diego | Phase 1/2 study for autologous human CD34+ hematopoietic stem cells ex vivo transduced with pCCL-CTNS lentiviral vector for treatment of Cystinosis. |
$11,999,944 |
| Late Stage Preclinical Projects | University of California, San Diego | Ex vivo transduced autologous human CD34+ hematopoietic stem cells for treatment of cystinosis |
$5,273,189 |
